hosted by
publicationslist.org
    

eftihia Hatziolou

Andreas Syggros Hospital for Skin and Venereal Diseases
Athens, Greece
5, Ionos Dragoumi st.16121, Athens, Greece
efchatz@gmail.com
E. Hatziolou is working in the Department of Histopathology-Andreas Syggros Hospital since 1987.
She is director of this department since 2008 January and she studies more than 7000 biopsies within a year.
She examines every specimen coming form both Dermatologic-pathologic department and plastic surgery of this hospital.
As this department is considered the most specialized as it concerns dermato-pathology in Greece, many items are sent here for a second histological opinion.

Journal articles

2009
N Zakopoulou, C Bokotas, M Frangoulis, D Karypidis, E Hatziolou, O Papadopoulos (2009)  Giant tumour of the heel: acquired fibrokeratoma.   Clin Exp Dermatol 34: 5. 605-606 Jul  
Abstract: Fibrokeratoma is a rare benign invasive tumour usually located on the digits. We report a 35-year-old patient with a giant acquired fibrokeratoma of the heel. Despite its large size and unusual location, the tumour was microscopically benign and was successfully excised.
Notes:
2008
Vasiliki A Nikolaou, Vana Sypsa, Irene Stefanaki, Helen Gogas, Othon Papadopoulos, Dorothea Polydorou, Michaela Plaka, Dimosthenis Tsoutsos, Anastasia Dimou, Eleni Mourtzoukou, Valantis Korfitis, Eftihia Hatziolou, Christina Antoniou, Angelos Hatzakis, Andreas Katsambas, Alexander J Stratigos (2008)  Risk associations of melanoma in a Southern European population: results of a case/control study.   Cancer Causes Control 19: 7. 671-679 Sep  
Abstract: OBJECTIVES: Limited data exist about the risk factors of melanoma in the Greek population. We investigated the association of melanoma with phenotypic and solar indices in this darker skin population residing in an environment of high ambient ultraviolet radiation. METHODS: Our study included 200 sporadic melanoma cases and 200 age-, sex-matched control subjects. Information on history of sun exposure patterns and cutaneous reaction to sunlight was obtained and a clinical evaluation of pigmentary traits, pigmented lesions, and actinic keratoses was performed. RESULTS: In the multivariate analysis, fair skin (OR: 4.63, for fair skin versus light brown, 95% CI: 1.54-13.92), intermittent sun exposure during childhood (OR: 3.33, >2 weeks/year of sun exposure versus < or =2 weeks/year 95% CI: 1.37-8.09), and outdoor leisure activities (OR: 2.74, 95% CI: 1.28-5.89), but not skin phototype or sunburns, were positively related to the risk of melanoma. In addition to an elevated count of common melanocytic nevi (OR: 6.27, > or =10 nevi versus no nevi, 95% CI: 1.65-23.76) and the presence of clinically atypical nevi (OR: 2.84, 95% CI: 1.16-6.98), solar lentigenes were an independent risk factor of melanoma (OR: 4.33, 95% CI: 1.67-11.22). CONCLUSIONS: Intermittent sun exposure of moderate intensity during childhood/adolescence and outdoor leisural activities, in conjunction with a more resistant skin phenotype to acute sunburns and a strong association with nevi and solar lentigenes was a prominent determinant of melanoma risk in our population.
Notes:
Haritini Petropoulou, George Politis, Pantelis Panagakis, Eftihia Hatziolou, Kiriaki Aroni, George Kontochristopoulos (2008)  Immunoglobulin A pemphigus associated with immunoglobulin A gammopathy and lung cancer.   J Dermatol 35: 6. 341-345 Jun  
Abstract: Immunoglobulin (Ig)A pemphigus is a rare disease marked by a vesiculopustular eruption characterized by intercellular IgA deposition in the epidermis. It has clinical and histopathological heterogeneity and encompasses two subgroups: subcorneal pustular dermatosis type and intraepidermal neutrophilic IgA dermatosis type. IgA pemphigus has been rarely associated with monoclonal IgA paraprotein, myeloma and B-cell lymphoma in the past. We report the first case, to our knowledge, of a 47-year-old male patient with a subcorneal pustular dermatosis type of IgA pemphigus associated with IgA gammopathy and lung cancer.
Notes:
2007
Markos Aivaliotis, Georgios Kontochristopoulos, Eftychia Hatziolou, Kyriaki Aroni, Niki Zakopoulou (2007)  Successful colchicine administration in facial granulomas caused by cosmetic implants: report of a case.   J Dermatolog Treat 18: 2. 112-114  
Abstract: Injectable cutaneous microimplants may occasionally cause either persistent local irritation or late skin reactions in the form of foreign body granulomas at the injected areas. Permanent elimination of the latter is not easily achieved. The skin of a female patient developed nodules along the treated sites on her face a few months following the last session of intracutaneous injections. Intralesional steroids offered temporary and incomplete clearance. Colchicine was administered orally for better results.
Notes:
2004
2002
S Georgala, A C Katoulis, C Georgala, E C Katoulis, E Hatziolou, N G Stavrianeas (2002)  Pretibial myxedema as the initial manifestation of Graves' disease.   J Eur Acad Dermatol Venereol 16: 4. 380-383 Jul  
Abstract: Pretibial myxedema (PM) is a localized thickening of the pretibial skin due to accumulation of acid mucopolysacharides (glycosaminoglycans). Its pathogenesis is still under investigation. Pretibial myxedema, exophthalmus and thyroid acropachy are the dassic extrathyroidal manifestations of Graves' disease. Almost invariably, PM follows the onset of ophthalmopathy, developing after the diagnosis and treatment of hyperthyroidism. Pretibial myxedema preceding Graves' ophthalmopathy is rare. We report the case of a 28-year-old Greek woman, who presented with multiple, asymptomatic nodules and plaques of the lower legs in the absence of other physical findings. Histopathologic examination revealed deposition of mucopolysacharides in the lower dermis. Laboratory investigation showed elevated serum T3 and T4 and depressed TSH levels. In our patient, pretibial myxedema was the earliest manifestation, leading to the diagnosis of Graves' disease.
Notes:
Francis Anthouli-Anagnostopoulou, Eftichia Hatziolou (2002)  Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases.   Adv Clin Path 6: 1. 17-24 Jan  
Abstract: BACKGROUND: Morphean basal cell carcinoma (BCC), is a distinct and aggressive skin cancer, usually requiring aggressive treatment from the start. OBJECTIVE: Assessment of the recurrences rate of morphean BCC and evaluation of significant prognostic factors for the clinical outcome of the neoplastic procedure. METHODS: 97 cases of morphean BCC were reviewed through last three years and special attention was paid to sex and age of the patient, size, location, histology and recurrences rate of the tumor. RESULTS: After a period ranged from two months to two years 14.8% of the cases recurred. The mean age of the patients was 64.4 years and there was slight women predominance (1.3/1). Morphean BCCs were observed mainly in nose (37.5%) and ear (12.5%) and showed an infiltrative growth pattern without inflammatory reaction (37.5%) in the histologic picture. CONCLUSIONS: Morphean BCC presents a high recurrence rate influenced by anatomic site, tumor histological appearance, tumor positive margins and type of treatment.
Notes:
N G Stavrianeas, A C Katoulis, A Kanelleas, E Hatziolou, S Georgala (2002)  Papulonodular lichenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination.   Dermatology 205: 2. 166-168  
Abstract: Immunization with the hepatitis B virus (HBV) is effective and safe with an estimated incidence of adverse reactions, either local or systemic, of less than 0.1%. Cutaneous side effects are rare and include lichen planus (LP) and lichenoid reactions. We report the case of a 21-year-old female, in whom a persistent, papulonodular lesion developed at the site of the injection, 6 weeks after the second dose of the HBV. Histological examination revealed lichenoid and pseudolymphomatous features. In addition, sensitization to thiomersal, a vaccine constituent, was documented by patch testing. The association of LP with chronic liver disease is well established. Furthermore, less than 20 cases of lichen or lichenoid reactions, following HBV vaccination, have been reported. Although several arguments have been presented, it is still debated whether there is a causal association or the occurrence of LP following HBV vaccination is a simple coincidence. It has been speculated that a T-cell-mediated, graft-versus-host-like reaction, triggered by a sensitizing protein, is directed against keratinocytes expressing an epitope of hepatitis B surface antigen or a similar epitope. Our case may represent a localized lichenoid reaction to HBV vaccination, a local reactive hyperplasia or a persisting delayed hypersensitivity reaction to a vaccine constituent. This is the first case of a local lichenoid reaction at the injection site of the HBV vaccine, providing further documentation for a causal association linking the HBV vaccine with LP.
Notes:
2001
G J Kontochristopoulos, D Exadaktylou, E Hatziolou, A Tassidou, N Zakopoulou (2001)  Follicular mucinosis associated with early stage cutaneous T-cell lymphoma: successful treatment with interferon alpha-2b and acitretin.   J Dermatolog Treat 12: 2. 117-121 Jun  
Abstract: BACKGROUND: Follicular mucinosis (FM) is a rare dermatosis characterized by mucin deposits in the pilosebaceous units. It is divided into a primary-benign type and a secondary type associated mostly with lymphomas. No standard effective therapy is available for the primary FM while in the secondary form treatment is aimed against the underlying disease. METHODS: We report a case of secondary FM in which a cutaneous T-cell lymphoma was detected 6 years after the initial eruption. RESULTS: Complete remission was achieved with combination therapy of interferon alpha-2b at a dose of 6 million U subcutaneously three times a week, and acitretin 35 mg/day, for 6 months. CONCLUSION: Regular clinical and histopathological evaluation is suggested for all patients with FM. For cases associated with cutaneous T-cell lymphoma the combination of interferon alpha and acitretin seems to be a good therapeutical approach.
Notes:
2000
F A Anthouli-Anagnostopoulou, E Hatziolou, G Papachristou, I Demoula (2000)  Juxtacortical osteosarcoma. A distinct malignant bone neoplasm.   Adv Clin Path 4: 3. 127-131 Jul  
Abstract: The purpose of this report is the study of a malignant bone tumor of similar histological picture with conventional (intramedullary) osteosarcoma. Contributing factors in the study of juxtacortical osteosarcoma are the clinical, X-ray and histologic pictures. A case of parosteal osteosarcoma in a 28-year-old male is reported. In conjuction with X-ray findings we review the histological characteristics of the tumor through serial sections of the peripheral, central and parosteal parts and the findings are described in detail. In addition to the histological findings, differential diagnosis and prognosis are also discussed. From the general study of the tumor it has been shown that juxtacortical osteogenic sarcoma behaves differently in contrast to classic osteosarcoma, depending on the degree of differentiation of the tumor.
Notes:
Powered by PublicationsList.org.